|
MechanismIL1R1 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shandong Yingtu Biotechnology Co., Ltd.
0 Patents (Medical) associated with Shandong Yingtu Biotechnology Co., Ltd.
100 Deals associated with Shandong Yingtu Biotechnology Co., Ltd.
100 Translational Medicine associated with Shandong Yingtu Biotechnology Co., Ltd.